Table 4.
First author | Published date/country | Study design | Study population | ECMO pts./total pts. | Age of ECMO pts. (years) | PaO2/FIO2a (mmHg) | MV durationa (day) | ECMO duration (days) | Discharged Aliveb, n (%) |
---|---|---|---|---|---|---|---|---|---|
Huang C [27] | January 24, 2020/Wuhan, China | Prospective/single centre | Ward and ICU | 2 /41 | NA | NA | NA | NA | NA |
Chen N [53] | January 30, 2020/Wuhan, China | Retrospective/single centre | Ward and ICU | 3/99 | NA | NA | NA | NA | NA |
Wang D [28] | February 07, 2020/Wuhan, China | Retrospective/single centre | Ward and ICU | 4 /138 | NA | NA | NA | NA | NA |
Yang X [29] | February 21, 2020/Wuhan, China | Retrospective/single centre | ICU | 6 /52 | NA | NA | NA | NA | 1 (16.7%) |
Guan W [54] | February 28, 2020/China | Prospective/multicentre | Ward and ICU | 5/1099 | NA | NA | NA | NA | NA |
Zhou F [30] | March 9, 2020/Wuhan, China | Retrospective/multicentre | Ward and ICU | 3/191 | NA | NA | NA | NA | 0/3 (0%) |
Li X [55] | March 30, 2020/Shanghai, China | Retrospective/multicentre | ICU | 8/16 | 64.3 ± 17.6 | 66.1 ± 7.8 | 9.7 ± 5.7 | 27.1 ± 17.7 | 3/7f |
Chen R [56] | April 11, 2020/China | Retrospective/multicentre | Ward and ICU 575 hospitals | 171/1590 | NA | NA | NA | NA | NA |
ELSO registry [57] | April 22, 2020/ELSO centres | – | ECMO | 487 | 49 (41–56) | 75 (62–100)c | 90 (34–135) | 190 (118–280)d | 36/90 (40%)e |
EuroELSO survey [58] | April 18, 2020/19 countries | – | ECMO | 820 | 52.4 | NA | NA | NA | NAf |
Mean ± SD or median (range)
ICU intensive care unit admission, MV mechanical ventilation, NA not applicable, pts. patients
aData before ECMO support
bDischarged alive of patients who underwent ECMO support
cFor 332 cases with data available among total 487 cases
dFor 200 cases that have completed their ECMO run
eFor only 109 cases those cases discharged alive/dead
f423 cases: ongoing, 217 cases: weaned, 189 cases: withdrawal for death